Stay updated on Rucaparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Rucaparib in Ovarian Cancer Clinical Trial page.

Latest updates to the Rucaparib in Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedGlossary display added; QC metadata updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data,' with older labels such as 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' removed and 'Revision: v3.3.4' replaced by 'Revision: v3.4.0'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page revision changed from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check50 days agoChange DetectedThe Locations section was expanded and reorganized to include numerous regional sites across the US, Canada, Australia, and Europe. Some locations were added (e.g., Arizona, California, New South Wales, Île-de-France) and others removed, in the v3.3.3 revision.SummaryDifference2%

- Check71 days agoChange DetectedA PubMed-based note about publications being automatically filled (and may not all pertain to the study) has been added, and the Revision label updated from v3.2.0 to v3.3.2.SummaryDifference0.4%

- Check78 days agoChange DetectedThe page removes a government funding/operating-status notice that was previously shown; core study details and navigation remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check100 days agoChange DetectedNo significant changes to the Study Details page content were detected between versions. Core information such as the study title, NCT number, design, eligibility criteria, primary outcomes, and locations remains the same.SummaryDifference0.2%

Stay in the know with updates to Rucaparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rucaparib in Ovarian Cancer Clinical Trial page.